About Us

Audit Diagnostics has been developing and manufacturing a comprehensive range of Diagnostic Solutions and Systems for the Healthcare market since 1993.

In our custom built State of the Art GMP manufacturing facility Audit Diagnostics develops and manufactures a comprehensive line of Ready to Use Liquid Stable Reagents including Clinical Chemistry, Immunoassay, TDM, DOA, Cytology, Elisa and Rapid Tests.

Through our network of distributors and OEM partners in over 100 countries, Audit Diagnostics provides these diagnostics reagents together with our Sapphire^® range of Clinical Analysers ranging from Semi-Automated through to 800 tests per hour Fully Automated Random Access.

Our dedicated TDM, DOA, Sapphire XT^® Analyser now completes the clinical range of systems.

Our recent introduction of the Worlds’ first complete Wet Chemistry Point of Care (POCT) Clinical Chemistry system Liqui-Stat^® now enables Fully Quantitative Diagnostic analysis of Clinical Chemistry, DOA, TDM and Immunoassay at point of care locations including Doctors office, Emergency rooms, Neonatal units, Veterinary laboratories, Satellite laboratories within 2-5 minutes which therefore provides Laboratory Quality Results at POCT locations.

The Sterl Stat^® unique decontamination range of products provides the “Total Sanitisation Solution” for all Healthcare, Food, and Veterinary environments where elimination of all Bacteria, Viruses and Infections is required.

Our Cellslide^®, Liquid Based Cytology (LBC) system now provides superior cytology preparations for Pap Tests, HPV, Urine and Thyroid applications.

Under the direction of our R&D teams, Audit Diagnostics will continue to introduce unique and Innovative Solutions to the market in the months and years ahead.

As a company focused on Innovative Research and Development, Audit Diagnostics is your partner to provide you with

“Healthcare Solutions for the Future”